Literature DB >> 9353502

Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study.

T Forsén1, J G Eriksson, J Tuomilehto, K Teramo, C Osmond, D J Barker.   

Abstract

OBJECTIVE: To determine whether restricted growth in utero is associated with an increased risk of coronary heart disease are among men in Finland, where rates of the disease are among the highest in the world.
DESIGN: Follow up study.
SETTING: Helsinki, Finland.
SUBJECTS: 3302 men born in Helsinki University Central Hospital during 1924-33 who went to school in the city of Helsinki and were resident in Finalnd in 1971. MAIN OUTCOME MEASURES: Standardised mortality ratios for coronary heart disease.
RESULTS: Men who were thin at birth, with low placental weight, had high death rates from coronary heart disease. Men whose mothers had a high body mass index in pregnancy also had high death rates. In a multivariate analysis the hazard ratio for coronary heart disease was 1.37 (95% confidence interval 1.20 to 1.57) (P < 0.0001) for every standard deviation decrease in ponderal index at birth and 1.24 (1.10 to 1.39) (P = 0.0004) for every standard deviation increase in mother's body mass index. The effect of mother's body mass index was restricted to mothers of below average stature.
CONCLUSION: These findings suggest a new explanation for the epidemics of coronary heart disease that accompany Westernisation. Chronically malnourished women are short and light and their babies tend to be thin. The immediate effect of improved nutrition is that women become fat, which seems to increase the risk of coronary heart disease in the next generation. With continued improvements in nutrition, women become taller and heavier; their babies are adequately nourished; and maternal fatness no longer increases the risk of coronary heart disease, which therefore declines.

Entities:  

Mesh:

Year:  1997        PMID: 9353502      PMCID: PMC2127571          DOI: 10.1136/bmj.315.7112.837

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  75 in total

1.  Twins and fetal programming of blood pressure. Questioning the role of genes and maternal nutrition.

Authors:  D A Leon
Journal:  BMJ       Date:  1999-11-20

2.  Early growth and cardiovascular disease.

Authors:  D J Barker
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

Review 3.  Fetal and infant markers of adult heart diseases.

Authors:  M R Järvelin
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

Review 4.  A new model for the origins of chronic disease.

Authors:  D J Barker
Journal:  Med Health Care Philos       Date:  2001

5.  Developmental Origins of Cardiovascular Disease.

Authors:  Edwina H Yeung; Candace Robledo; Nansi Boghossian; Cuilin Zhang; Pauline Mendola
Journal:  Curr Epidemiol Rep       Date:  2014-03-01

6.  Mother's body size and placental size predict coronary heart disease in men.

Authors:  Johan G Eriksson; Eero Kajantie; Kent L Thornburg; Clive Osmond; David J P Barker
Journal:  Eur Heart J       Date:  2011-06-01       Impact factor: 29.983

7.  Fetal serum folate concentrations and placental folate transport in obese women.

Authors:  Margaret F Carter; Theresa L Powell; Cun Li; Leslie Myatt; Donald Dudley; Peter Nathanielsz; Thomas Jansson
Journal:  Am J Obstet Gynecol       Date:  2011-02-23       Impact factor: 8.661

8.  The early origins of chronic heart failure: impaired placental growth and initiation of insulin resistance in childhood.

Authors:  David J P Barker; Jill Gelow; Kent Thornburg; Clive Osmond; Eero Kajantie; Johan G Eriksson
Journal:  Eur J Heart Fail       Date:  2010-05-26       Impact factor: 15.534

9.  The placenta is the center of the chronic disease universe.

Authors:  Kent L Thornburg; Nicole Marshall
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

Review 10.  Early growth and adult health outcomes--lessons learned from the Helsinki Birth Cohort Study.

Authors:  Johan G Eriksson
Journal:  Matern Child Nutr       Date:  2005-07       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.